- Home
- BNR vs NVNI Comparison
BNR vs NVNI Comparison
Compare BNR & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- NVNI
- Stock Information
- Founded
- BNR 2014
- NVNI 2019
- Country
- BNR China
- NVNI Brazil
- Employees
- BNR N/A
- NVNI N/A
- Industry
- BNR Medical Specialities
- NVNI
- Sector
- BNR Health Care
- NVNI
- Exchange
- BNR Nasdaq
- NVNI Nasdaq
- Market Cap
- BNR 38.3M
- NVNI 31.5M
- IPO Year
- BNR 2020
- NVNI N/A
- Fundamental
- Price
- BNR $4.87
- NVNI $0.34
- Analyst Decision
- BNR
- NVNI
- Analyst Count
- BNR 0
- NVNI 0
- Target Price
- BNR N/A
- NVNI N/A
- AVG Volume (30 Days)
- BNR 29.7K
- NVNI 1.3M
- Earning Date
- BNR 08-21-2025
- NVNI 08-07-2025
- Dividend Yield
- BNR N/A
- NVNI N/A
- EPS Growth
- BNR N/A
- NVNI N/A
- EPS
- BNR N/A
- NVNI N/A
- Revenue
- BNR $72,112,038.00
- NVNI $31,250,627.00
- Revenue This Year
- BNR $136.32
- NVNI $12.05
- Revenue Next Year
- BNR N/A
- NVNI $15.02
- P/E Ratio
- BNR N/A
- NVNI N/A
- Revenue Growth
- BNR 0.53
- NVNI 1491.58
- 52 Week Low
- BNR $2.18
- NVNI $0.14
- 52 Week High
- BNR $7.90
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- NVNI 50.94
- Support Level
- BNR $3.06
- NVNI $0.31
- Resistance Level
- BNR $3.50
- NVNI $0.38
- Average True Range (ATR)
- BNR 0.21
- NVNI 0.03
- MACD
- BNR 0.05
- NVNI 0.01
- Stochastic Oscillator
- BNR 95.65
- NVNI 63.05
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.